Michael A. Goulder

1.1k total citations
17 papers, 828 citations indexed

About

Michael A. Goulder is a scholar working on Cardiology and Cardiovascular Medicine, Pharmacology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Michael A. Goulder has authored 17 papers receiving a total of 828 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Cardiology and Cardiovascular Medicine, 5 papers in Pharmacology and 4 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Michael A. Goulder's work include Heart Failure Treatment and Management (5 papers), Respiratory and Cough-Related Research (3 papers) and Cardiac electrophysiology and arrhythmias (3 papers). Michael A. Goulder is often cited by papers focused on Heart Failure Treatment and Management (5 papers), Respiratory and Cough-Related Research (3 papers) and Cardiac electrophysiology and arrhythmias (3 papers). Michael A. Goulder collaborates with scholars based in United Kingdom, Sweden and Netherlands. Michael A. Goulder's co-authors include Ian Smith, Sue Aspley, Iain A. Gibb, S. Reader, Stephen E. Daniels, Nicholas S. Hill, Michael Doherty, Adrian Shephard, Christopher J. Hawkey and Alice King and has published in prestigious journals such as Journal of the American College of Cardiology, Stroke and Pain.

In The Last Decade

Michael A. Goulder

17 papers receiving 789 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael A. Goulder United Kingdom 16 261 150 150 144 123 17 828
Guillermo Di Girolamo Argentina 22 116 0.4× 87 0.6× 241 1.6× 159 1.1× 312 2.5× 107 1.3k
C. Andrew Robinson United States 17 108 0.4× 112 0.7× 39 0.3× 123 0.9× 70 0.6× 43 840
Sarayut Janmahasatian Australia 2 155 0.6× 95 0.6× 78 0.5× 125 0.9× 34 0.3× 2 676
Salvatore Mannino Italy 14 59 0.2× 165 1.1× 155 1.0× 142 1.0× 155 1.3× 27 786
L. V. Wilton United Kingdom 15 161 0.6× 57 0.4× 119 0.8× 90 0.6× 138 1.1× 22 816
Sandra Solari Chile 18 59 0.2× 90 0.6× 158 1.1× 336 2.3× 84 0.7× 56 1.1k
Kent E. Opheim United States 17 111 0.4× 41 0.3× 47 0.3× 138 1.0× 70 0.6× 46 991
Bény Charbit France 14 51 0.2× 55 0.4× 363 2.4× 336 2.3× 85 0.7× 31 1.3k
Cheryl Renz United States 13 682 2.6× 427 2.8× 97 0.6× 187 1.3× 189 1.5× 27 1.5k
R. S. Nanra Australia 16 269 1.0× 36 0.2× 102 0.7× 162 1.1× 68 0.6× 46 848

Countries citing papers authored by Michael A. Goulder

Since Specialization
Citations

This map shows the geographic impact of Michael A. Goulder's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael A. Goulder with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael A. Goulder more than expected).

Fields of papers citing papers by Michael A. Goulder

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael A. Goulder. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael A. Goulder. The network helps show where Michael A. Goulder may publish in the future.

Co-authorship network of co-authors of Michael A. Goulder

This figure shows the co-authorship network connecting the top 25 collaborators of Michael A. Goulder. A scholar is included among the top collaborators of Michael A. Goulder based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael A. Goulder. Michael A. Goulder is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Funck‐Brentano, Christian, Dirk J. van Veldhuisen, Louis L.M. van de Ven, et al.. (2011). Influence of Order and Type of Drug (Bisoprolol vs. Enalapril) on Outcome and Adverse Events in Patients with Chronic Heart Failure: A post hoc Analysis of the CIBIS-III Trial. European Journal of Heart Failure. 13(7). 765–772. 20 indexed citations
2.
Doherty, Michael, Christopher J. Hawkey, Michael A. Goulder, et al.. (2011). A randomised controlled trial of ibuprofen, paracetamol or a combination tablet of ibuprofen/paracetamol in community-derived people with knee pain. Annals of the Rheumatic Diseases. 70(9). 1534–1541. 115 indexed citations
3.
Wade, Alan, Christopher Morris, Adrian Shephard, G. Crawford, & Michael A. Goulder. (2011). A multicentre, randomised, double-blind, single-dose study assessing the efficacy of AMC/DCBA Warm lozenge or AMC/DCBA Cool lozenge in the relief of acute sore throat. BMC Family Practice. 12(1). 6–6. 32 indexed citations
4.
5.
Rosenson, Robert S., Heather Fraser, Michael A. Goulder, & Colin Hislop. (2011). Anti-Inflammatory Effects of Varespladib Methyl in Diabetic Patients with Acute Coronary Syndrome. Cardiovascular Drugs and Therapy. 25(6). 539–544. 15 indexed citations
6.
Markus, Hugh S., et al.. (2011). The von Willebrand Inhibitor ARC1779 Reduces Cerebral Embolization After Carotid Endarterectomy. Stroke. 42(8). 2149–2153. 89 indexed citations
7.
Krum, Henry, Dirk J. van Veldhuisen, Christian Funck‐Brentano, et al.. (2010). Effect on Mode of Death of Heart Failure Treatment Started with Bisoprolol Followed by Enalapril, Compared to the Opposite Order: Results of the Randomized CIBIS III Trial. Cardiovascular Therapeutics. 29(2). 89–98. 17 indexed citations
8.
Rosenson, Robert S., Colin Hislop, Michael D. Elliott, et al.. (2010). Effects of Varespladib Methyl on Biomarkers and Major Cardiovascular Events in Acute Coronary Syndrome Patients. Journal of the American College of Cardiology. 56(14). 1079–1088. 69 indexed citations
9.
Ven, Louis L.M. van de, et al.. (2009). The effect of treatment with bisoprolol-first versus enalapril-first on cardiac structure and function in heart failure. International Journal of Cardiology. 144(1). 59–63. 9 indexed citations
10.
Simpson, M., et al.. (2009). Rapid relief of acute sore throat with AMC/DCBA throat lozenges: randomised controlled trial. International Journal of Clinical Practice. 64(2). 194–207. 34 indexed citations
11.
Connor, Mark, Colin Church, S. Reader, et al.. (2009). Scintigraphy can be used to compare delivery of sore throat formulations. International Journal of Clinical Practice. 63(4). 606–612. 23 indexed citations
12.
13.
Dobre, Daniela, Dirk J. van Veldhuisen, Michael A. Goulder, Henry Krum, & Ronnie Willenheimer. (2008). Clinical Effects of Initial 6 Months Monotherapy with Bisoprolol versus Enalapril in the Treatment of Patients with Mild to Moderate Chronic Heart Failure. Data from the CIBIS III Trial. Cardiovascular Drugs and Therapy. 22(5). 399–405. 15 indexed citations
14.
Giugliano, Robert P., Stephen D. Wiviott, Peter H. Stone, et al.. (2007). Recombinant Nematode Anticoagulant Protein c2 in Patients With Non–ST-Segment Elevation Acute Coronary Syndrome. Journal of the American College of Cardiology. 49(25). 2398–2407. 58 indexed citations
15.
Autret‐Leca, E., Iain A. Gibb, & Michael A. Goulder. (2007). Ibuprofen versus paracetamol in pediatric fever: objective and subjective findings from a randomized, blinded study. Current Medical Research and Opinion. 23(9). 2205–2211. 35 indexed citations
16.
Astrup, Arne, S Toubro, Nick Finer, et al.. (2001). Predictors of weight loss and maintenance during 2 years of treatment by sibutramine in obesity. Results from the European multi-centre STORM trial. International Journal of Obesity. 25(4). 496–501. 85 indexed citations
17.
Smith, Ian, et al.. (2001). Randomized placebo-controlled trial of long-term treatment with sibutramine in mild to moderate obesity.. PubMed. 50(6). 505–12. 123 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Guillermo Di Girolamo Breakdown of academic impact, for papers by C. Andrew Robinson Breakdown of academic impact, for papers by Sarayut Janmahasatian Breakdown of academic impact, for papers by Salvatore Mannino Breakdown of academic impact, for papers by L. V. Wilton Breakdown of academic impact, for papers by Sandra Solari Breakdown of academic impact, for papers by Kent E. Opheim Breakdown of academic impact, for papers by Bény Charbit Breakdown of academic impact, for papers by Cheryl Renz Breakdown of academic impact, for papers by R. S. Nanra
Rankless by CCL
2026